Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| RE49697 | Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations | Wilfried Schwab, Alexander Birkmann, Kurt Vogtli, Dieter Haag, Stephan Maas +1 more | 2023-10-17 |
| 10603384 | Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative | Wilfried Schwab, Dominique Grunder, Peter Van Hoogevest | 2020-03-31 |
| 10137117 | Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations | Wilfried Schwab, Alexander Birkmann, Kurt Vogtli, Dieter Haag, Stephan Maas +1 more | 2018-11-27 |
| 9889124 | Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations | Wilfried Schwab, Alexander Birkmann, Kurt Vogtli, Dieter Haag, Stephan Maas +1 more | 2018-02-13 |
| 9637459 | Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents | Alfons Grunenberg, Mathias Berwe, Birgit Keil, Edwin Aret, Wilfried Schwab | 2017-05-02 |
| 9592225 | Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations | Wilfried Schwab, Alexander Birkmann, Kurt Vogtli, Dieter Haag, Stephan Maas +1 more | 2017-03-14 |
| 9119786 | Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations | Wilfried Schwab, Alexander Birkmann, Kurt Vogtli, Dieter Haag, Stephan Maas +1 more | 2015-09-01 |
| 8501723 | Pharmaceutical compositions comprising fesoterodine | Hans-Jurgen Mika, Christoph Arth, Michael Komenda, Fatima Bicane, Meike IRNGARTINGER +1 more | 2013-08-06 |